To comparatively characterize BRDT-PTEFb and BRD4-PTEFb complexes, we first conducted size exclusion chromatography using whole nuclear extracts from NCI-H510 lung cancer patient-derived cells, which express relatively high levels of BRDT at both the mRNA and protein level (Fig. 1A and fig. The gene discussed is BRDT; the disease is lung carcinoma.